Quantcast

Latest Spring Bank Pharmaceuticals Inc. Stories

2014-06-23 08:28:39

MILFORD, Mass., June 23, 2014 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel drugs to treat a number of medical conditions, with a primary focus in antivirals, today announced two presentations at the Nucleic Acid Summit 2014 held June 19-20, 2014 in San Diego. "The research presented continues to expand our understanding of small molecule nucleic acid hybrids (SMNH) and the underlying...

2014-05-12 08:30:57

MILFORD, Mass., May 12, 2014 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel drugs to treat a number of medical conditions, with a primary focus in antivirals, today announced three presentations on SB 9200, its lead drug candidate for the treatment of Hepatitis B (HBV) and Hepatitis C (HCV) infections, at the 27th International Conference on Antiviral Research (ICAR) being held May 12-16, 2014 at the...

2014-01-28 12:29:36

Seasoned Executive Brings Extensive Track Record of Business and Financial Experience to Clinical Stage Company MILFORD, Mass., Jan. 28, 2014 /PRNewswire/ -- Spring Bank Pharmaceuticals today announced that David Arkowitz has been appointed to its Board of Directors. Mr. Arkowitz has more than two decades of finance and operations leadership in the healthcare, life sciences and biotechnology industries. He will help guide Spring Bank's growth with a focus on optimizing the...

2011-05-05 12:04:00

MILFORD, Mass., May 5, 2011 /PRNewswire/ -- Spring Bank Pharmaceuticals today announced it has been awarded an RO1 grant from the National Institute of Health, National Institute of Allergy and Infectious Diseases for the development of SB 9200, a novel, orally bioavailable agent for the treatment of Hepatitis B virus infection. Under the terms of this award, Spring Bank Pharmaceuticals will receive $3.9 million over five years in support of its development efforts. This is the fourth...

2011-03-03 11:24:00

MILFORD, Mass., March 3, 2011 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc. today announced that Nezam H. Afdhal, M.D. has joined the company as Chair of our Clinical Advisory Board and a member of our Scientific Advisory Board. Dr. Afdhal is a recognized thought leader in the treatment of hepatitis and the development of new antiviral therapies for the treatment of Hepatitis B and C infection. Douglas Jensen, CEO, Spring Bank Pharmaceuticals, stated, "We are very pleased that we...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related